References

  1. Y Bacq. Hepatitis B and pregnancy. Gastroenterol Clin Biol. 2008 Jan; 32(1 Pt 2):S12-9. PubMed | Google Scholar

  2. Del Canho R, Grosheide PM, Mazel JA, et al. Ten-year neonatal hepatitis B, vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine. 1997;(15) : 1624-1630. PubMed | Google Scholar

  3. Zou H. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HbsAgpositive mothers. J Viral Hepat. 2012 Feb ; 19 (2) : e18-25. PubMed | Google Scholar

  4. Chakvetadze C, Roussin C, Roux J, Mallet V, Petinelli ME, Pol S. Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive Mothers. Vaccine. 2011 ; 29 (16) : 2846-9. PubMed | Google Scholar

  5. Giles ML, Grace R, Tai A, Michalak K, Walker SP. Prevention of mother-to-child transmission of hepatitis B virus (HBV) during pregnancy and the puerperium: current standards of care. Aust N Z J ObstetGynaecol. 2013 ; 53 (3) : 231-5. PubMed | Google Scholar

  6. Shi, Zhongjie MD; Yang, Yuebo MD; Ma. Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B Virus: A Systematic Review and Meta-Analysis. The American College of Obstetricians and Gynecologists. 2010 ; 116 (1) : 147-159. PubMed | Google Scholar

  7. Jiang HX, Han GR, Wang CM, Ji Y. Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highlyviremic mothers with HbeAg + chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi. 2012; 0 (12 ): 888-91. PubMed | Google Scholar

  8. Kose S, M Turken et al. Efficacy and safety of lamivudine treatment in late pregnancy with high HBV DNA: a perspective for mother and infants. J Infect Dev Ctries. 2011 Apr 26; 5(4):303-6. PubMed | Google Scholar

  9. Han L, Zhang HW, Xie JX, Zhang Q, Wang HY, Cao GW. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol. 2011 Oct 14;17(38):4321-33. PubMed | Google Scholar

  10. Yi W, Liu M, Cai HD. Safety of lamivudine treatment for chronic hepatitis B in early pregnancy.World J Gastroenterol. 2012 Dec 7;18(45):6645-50. PubMed | Google Scholar

  11. Yu M, Y Ji, et al. Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virus. Int J Gynaecol Obstet. 2011 Jul;114(1):33-6. PubMed | Google Scholar